
Reporting by pharma companies on spending on physicians is becoming a non-event
Last year's decision will cost US hospitals $300 million, says Novation-led group
Emphasis of 'physician preference items' in healthcare distribution
Analysis from Prime Therapeutics points to severe cost hurdles for biosimilars developed and marketed in the US
However, most payers will continue to adjust their drug coverage
Step-by-step process for addressing potential shortages is outlined
Identity Hub expedites access to regulated content in clinical research; now, prescribing and other commercial applications are being adopted
Collaboration with American College of Cardiology could result in new health-outcomes results
Nearly 100 cargo stations have been enhanced for pharma cold-chain distribution
First of what are expected to be many global 3PL sites, especially for specialty pharmaceuticals
Service eases the management of domestic US shipments to trading partners and patients
Vaccine trials will continue without a clear path forward
KoolTemp GTS Instant avoids use--and cost--of refrigerants
Whole blood use is declining while plasma-derived product consumption rises
Annual specialty-distribution study focuses trend in oncology, chronic diseases
More executional capabilities derive from affiliation with parent, inVentiv Health
Company uses online media to promote fill rates by over 50%
$296-million bid makes it the 'stalking horse' buyer in Dendreon auction
Roughly 40% are for rare diseases; PD-1 oncolytics capture industry attention
Mapi Group casts itself as a leading 'health research and commercialization' player
'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney
So long WAG, hello to WBA as pharma manufacturers look at a consolidating buyer landscape
Pharmacists' ranking, continuing a two-year decline, is now neck-and-neck with doctors
Express Scripts touts a 'fundamental change' in drug pricing; others would call it negotiating a discount
Acquisition builds on Dohmen's rare-disease business
Poltraf acquisition adds to a network of 14 facilities serving Eastern and Western Europe
Will formularies become a consumer's concern for healthcare provision?
The broad changes taking place in the pharma supply chain this year are a relevant focus for the annual conference and exhibition